[Therapeutic target for the use of erythropoietin (EPO): is subnormal better than normal?].
Karle
Hans
H
hanskarle@dadlnet.dk
Hansen
Niels Ebbe
NE
D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D004921:Erythropoietin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000150:complications; D012307:Risk Factors
D006454:Hemoglobins; D004921:Erythropoietin